Merck (MRK) Tops Q1 EPS by 17c, Updates FY Guidance

Merck (NYSE: MRK) reported Q1 EPS of $1.22, $0.17 better than the analyst estimate of $1.05. Revenue for the quarter came in at $10.8 billion versus the consensus estimate of $10.48 billion.

GUIDANCE:

Merck sees FY2019 EPS of $4.67-$4.79, versus the consensus of $4.67. Merck sees FY2019 revenue of $43.9-45.1 billion, versus the consensus of $44.42 billion.

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• KinderCare Learning Companies, Inc. (KLC) Misses Q2 EPS by 2c; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c